Regulation of human immunodeficiency virus replication - PubMed (original) (raw)

Review

Regulation of human immunodeficiency virus replication

B R Cullen. Annu Rev Microbiol. 1991.

No abstract available

PubMed Disclaimer

Similar articles

• An immune control model for viral replication in the CNS during presymptomatic HIV infection.
  McCrossan M, Marsden M, Carnie FW, Minnis S, Hansoti B, Anthony IC, Brettle RP, Bell JE, Simmonds P. McCrossan M, et al. Brain. 2006 Feb;129(Pt 2):503-16. doi: 10.1093/brain/awh695. Epub 2005 Nov 29. Brain. 2006. PMID: 16317019
• [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
  Schwartz C, Le Douce V, Cherrier T, Redel L, Marban C, Aunis D, Rohr O. Schwartz C, et al. Med Sci (Paris). 2010 Feb;26(2):159-63. doi: 10.1051/medsci/2010262159. Med Sci (Paris). 2010. PMID: 20188047 Review. French.
• Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
  Rounseville MP, Lin HC, Agbottah E, Shukla RR, Rabson AB, Kumar A. Rounseville MP, et al. Virology. 1996 Feb 15;216(2):411-7. doi: 10.1006/viro.1996.0077. Virology. 1996. PMID: 8607271
• HIV-1 replication and potential targets for intervention.
  Stevenson M, Bukrinsky M, Haggerty S. Stevenson M, et al. AIDS Res Hum Retroviruses. 1992 Feb;8(2):107-17. doi: 10.1089/aid.1992.8.107. AIDS Res Hum Retroviruses. 1992. PMID: 1540400 Review.

Cited by

• HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.
  Nonnemacher MR, Pirrone V, Feng R, Moldover B, Passic S, Aiamkitsumrit B, Dampier W, Wojno A, Kilareski E, Blakey B, Ku TS, Shah S, Sullivan NT, Jacobson JM, Wigdahl B. Nonnemacher MR, et al. PLoS One. 2016 Apr 21;11(4):e0150835. doi: 10.1371/journal.pone.0150835. eCollection 2016. PLoS One. 2016. PMID: 27100290 Free PMC article.
• The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef.
  Anderson SJ, Lenburg M, Landau NR, Garcia JV. Anderson SJ, et al. J Virol. 1994 May;68(5):3092-101. doi: 10.1128/JVI.68.5.3092-3101.1994. J Virol. 1994. PMID: 8151774 Free PMC article.
• Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.
  Navarro J, Punzón C, Jiménez JL, Fernández-Cruz E, Pizarro A, Fresno M, Muñoz-Fernández MA. Navarro J, et al. J Virol. 1998 Jun;72(6):4712-20. doi: 10.1128/JVI.72.6.4712-4720.1998. J Virol. 1998. PMID: 9573235 Free PMC article.
• Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection.
  Shapira-Nahor O, Marcus H, Segall H, Lubin I, Slavin S, Panet A, Reisner Y. Shapira-Nahor O, et al. J Virol. 1997 Jun;71(6):4495-501. doi: 10.1128/JVI.71.6.4495-4501.1997. J Virol. 1997. PMID: 9151841 Free PMC article.
• U1 small nuclear ribonucleoprotein and splicing inhibition by the rous sarcoma virus negative regulator of splicing element.
  McNally LM, McNally MT. McNally LM, et al. J Virol. 1999 Mar;73(3):2385-93. doi: 10.1128/JVI.73.3.2385-2393.1999. J Virol. 1999. PMID: 9971822 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information